Cullinan Therapeutics Inc (CGEM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	37.82% 75.80	55.00	48.85	50.03	42.99
Operating Income/Loss	37.82% -75.80	-55.00	-48.85	-50.03	-42.99
Income/Loss From Continuing Operations Before Tax	44.44% -70.06	-48.50	-40.56	-42.03	-37.34
Income/Loss From Continuing Operations After Tax	44.44% -70.06	-48.50	-40.56	-42.03	-37.34
Net Income/Loss	44.44% -70.06	-48.50	-40.56	-42.03	-37.34
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-0.192
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RVMD

$102.71

28.63%

GMAB

$33.90

2.42%

INCY

$110.57

3.67%

BNTX

$100.08

2.03%

ONC

$333.87

4.22%

INSM

$176.00

0.53%